These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 12841544

  • 1. Rapid suppression of bone resorption and parathyroid hormone secretion by acute oral administration of calcium in healthy adult men.
    Ortolani S, Scotti A, Cherubini R.
    J Endocrinol Invest; 2003 Apr; 26(4):353-8. PubMed ID: 12841544
    [Abstract] [Full Text] [Related]

  • 2. An acute intake of phosphate increases parathyroid hormone secretion and inhibits bone formation in young women.
    Kärkkäinen M, Lamberg-Allardt C.
    J Bone Miner Res; 1996 Dec; 11(12):1905-12. PubMed ID: 8970892
    [Abstract] [Full Text] [Related]

  • 3. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
    Leder BZ, Smith MR, Fallon MA, Lee ML, Finkelstein JS.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):511-6. PubMed ID: 11158001
    [Abstract] [Full Text] [Related]

  • 4. The effect of calcium supplementation on the circadian rhythm of bone resorption.
    Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR, Eastell R.
    J Clin Endocrinol Metab; 1994 Sep; 79(3):730-5. PubMed ID: 8077353
    [Abstract] [Full Text] [Related]

  • 5. Nocturnal rise in markers of bone resorption is not abolished by bedtime calcium or calcitonin.
    Sairanen S, Tähtelä R, Laitinen K, Karonen SL, Välimäki MJ.
    Calcif Tissue Int; 1994 Nov; 55(5):349-52. PubMed ID: 7866915
    [Abstract] [Full Text] [Related]

  • 6. Acute effects in healthy women of oral calcium on the calcium-parathyroid axis and bone resorption as assessed by serum beta-CrossLaps.
    Zikán V, Haas T, Stepan JJ.
    Calcif Tissue Int; 2001 Jun; 68(6):352-7. PubMed ID: 11685423
    [Abstract] [Full Text] [Related]

  • 7. Impact of supplementary high calcium milk with additional magnesium on parathyroid hormone and biochemical markers of bone turnover in postmenopausal women.
    Green JH, Booth C, Bunning R.
    Asia Pac J Clin Nutr; 2002 Jun; 11(4):268-73. PubMed ID: 12495258
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
    Tankó LB, Bagger YZ, Alexandersen P, Devogelaer JP, Reginster JY, Chick R, Olson M, Benmammar H, Mindeholm L, Azria M, Christiansen C.
    J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of short-term treatment with clodronate on parameters of bone metabolism and their diurnal variation.
    Sairanen S, Tähtelä R, Laitinen K, Löyttyniemi E, Välimäki MJ.
    Calcif Tissue Int; 1997 Feb; 60(2):160-3. PubMed ID: 9056164
    [Abstract] [Full Text] [Related]

  • 15. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 16. Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption.
    McKane WR, Khosla S, Egan KS, Robins SP, Burritt MF, Riggs BL.
    J Clin Endocrinol Metab; 1996 May; 81(5):1699-703. PubMed ID: 8626819
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
    Vinholes J, Guo CY, Purohit OP, Eastell R, Coleman RE.
    J Clin Oncol; 1997 Jan; 15(1):131-8. PubMed ID: 8996134
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.